Leukemia, T-Cell

T-cell leukemia includes various types of lymphoid leukemia that affect T cells. Here is the latest research on T-cell leukemia.

September 16, 2021
Review

PBX1: a key character of the hallmarks of cancer.

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Rafaela Nasser VeigaDaniela Fiori Gradia
September 16, 2021
Open Access

TP53 lacks tetramerization and N-terminal domains due to novel inactivating mutations detected in leukemia patients.

Journal of Cancer Research and Therapeutics
Yasir Hameed, Samina Ejaz
September 16, 2021

Self-regressing oral CD30-positive, EBV-negative, T-cell lymphoproliferative lesions. A poorly understood process highlighted by ominous clinicopathologic features and indolent behavior.

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Prokopios P ArgyrisIoannis G Koutlas
September 16, 2021
Open Access

TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma.

Cancer Cell International
Cunte ChenYangqiu Li
September 16, 2021

Outcomes of Acute Lymphoblastic Leukemia with KMT2A (MLL) rearrangement - The MD Anderson Experience.

Blood Advances
Guillaume Richard-CarpentierElias J Jabbour
September 16, 2021

Update on the Classification and Diagnostic Approaches of Mature T-Cell Lymphomas.

Archives of Pathology & Laboratory Medicine
Xiaohui ZhangLinsheng Zhang
September 16, 2021
Open Access

KCTD15 deregulation is associated with alterations of the NF-κB signaling in both pathological and physiological model systems.

Scientific Reports
Giovanni SmaldonePeppino Mirabelli
September 15, 2021

Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cells.

Cell Biology and Toxicology
Andrea Ghelli Luserna Di RoràGiorgia Simonetti
September 15, 2021
Preprint
Open Access

Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients.

MedRxiv : the Preprint Server for Health Sciences
Zoe L LyskiStephen E Spurgeon
September 15, 2021

Full-length HLA sequencing in adult T cell leukemia-lymphoma uncovers multiple gene alterations.

Leukemia
Keita TamakiHiroaki Masuzaki
September 14, 2021

HEREDITARY LEIOMYOMATOSIS AND ACUTE LYMPHOBLASTIC LEUKEMIA: a LINK THROUGH FUMARATE DYSHYDRATASE MUTATION?

Acta Clinica Belgica
Sophie BailleuxArjen F Nikkels
September 14, 2021

Diagnostic utility of programmed cell death ligand 1 (clone SP142) immunohistochemistry for malignant lymphoma and lymphoproliferative disorders: A brief review.

Journal of Clinical and Experimental Hematopathology : JCEH
Ayako SakakibaraNaoko Asano
September 13, 2021
Review

Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age.

Andrology
Alexander W PastuszakMartin M Miner
September 13, 2021
Review

EBV-specific Cytotoxic T Lymphocytes for Refractory EBV-associated Post-transplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients: a Systematic Review.

Transplant International : Official Journal of the European Society for Organ Transplantation
Jing-Yi LiuLin Wei

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Bone Marrow Neoplasms

Bone Marrow Neoplasms are cancers that occur in the bone marrow. Discover the latest research on Bone Marrow Neoplasms here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Castleman Disease

Castleman disease is a rare disorder that involves an overgrowth of cells in the lymph nodes. Unicentric Castleman disease affects one lymph node, usually in the chest or abdomen. Multicentric Castleman disease affects multiple lymph nodes, commonly located in the neck, collarbone, underarm and groin areas. Discover the latest research on Castleman disease here.

Childhood Vascular Tumor: Genetics

Childhood vascular tumors are formed from cells related to blood vessels or lymph vessels. Here is the latest research on the genetics of childhood vascular tumors.

Chronic Myelogenous Leukemia

Chronic myelogenous leukemia (cml) is a clonal hematopoietic stem cell disorder characterized by the translocation and resultant production of the constitutively activated bcr-abl tyrosine kinase. Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/leukemia-t-cell/2190170e-bc5f-4932-93c6-870c93ebe4de